Clomipramine Hydrochloride Capsules recalls: lots, NDC and companies
3 FDA recall records mention Clomipramine Hydrochloride Capsules since April 30, 2025. Each covers specific lots from one company. Check yours below.
Check your Clomipramine Hydrochloride Capsules bottle
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Zydus Pharmaceuticals (USA) Inc: clomiPRAMINE Hydrochloride and 2 more
Hazard (FDA): cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
FDAMedicines
Lupin Pharmaceuticals Inc.: clomiPRAMINE Hydrochloride Capsules USP 25 mg
Hazard (FDA): Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
FDAMedicines
Lupin Pharmaceuticals Inc.: clomiPRAMINE hydrochloride Capsules USP
Hazard (FDA): Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.
FDAMedicines